Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Evolving management strategies for heparin-induced thrombocytopenia.

Rice L.

Semin Hematol. 2005 Jul;42(3 Suppl 3):S15-21. Review.

PMID:
16105554
2.
3.

Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.

Jeske WP, Walenga JM.

Curr Opin Investig Drugs. 2002 Aug;3(8):1171-80. Review.

PMID:
12211410
4.

Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.

Dang CH, Durkalski VL, Nappi JM.

Pharmacotherapy. 2006 Apr;26(4):461-8.

PMID:
16553503
5.

Current agents for the treatment of patients with heparin-induced thrombocytopenia.

Warkentin TE.

Curr Opin Pulm Med. 2002 Sep;8(5):405-12. Review.

PMID:
12172444
6.

Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.

Lewis BE, Hursting MJ.

Expert Rev Cardiovasc Ther. 2007 Jan;5(1):57-68. Review.

PMID:
17187457
7.

Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia.

Srinivasan AF, Rice L, Bartholomew JR, Rangaswamy C, La Perna L, Thompson JE, Murphy S, Baker KR.

Arch Intern Med. 2004 Jan 12;164(1):66-70.

PMID:
14718324
8.
9.

Heparin-induced thrombocytopenia from venous thromboembolism treatment.

Begelman SM, Hursting MJ, Aghababian RV, McCollum D.

J Intern Med. 2005 Dec;258(6):563-72.

10.

[Argatroban treatment of heparin-induced immune-mediated thrombocytopenia].

Nielsen JD, Heslet L.

Ugeskr Laeger. 2009 Feb 16;171(8):610-1. Danish.

PMID:
19284906
11.
12.

Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.

Burger CF, Schlesinger JJ.

Ann Pharmacother. 2014 Feb;48(2):286-91. doi: 10.1177/1060028013511060. Epub 2013 Nov 6.

PMID:
24259642
13.

Venous thromboembolism in heparin-induced thrombocytopenia.

Warkentin TE.

Curr Opin Pulm Med. 2000 Jul;6(4):343-51. Review.

PMID:
10912644
14.

Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.

Nielsen VG, Steenwyk BL, Gurley WQ, Pereira SJ, Lell WA, Kirklin JK.

J Heart Lung Transplant. 2006 Jun;25(6):653-63. Epub 2006 May 2.

PMID:
16730571
15.
16.

The approach to heparin-induced thrombocytopenia.

Linkins LA, Warkentin TE.

Semin Respir Crit Care Med. 2008 Feb;29(1):66-74. doi: 10.1055/s-2008-1047564. Review.

PMID:
18302088
17.

Argatroban use in heparin-induced thrombocytopenia.

Boggio LN, Oza VM.

Expert Opin Pharmacother. 2008 Aug;9(11):1963-7. doi: 10.1517/14656566.9.11.1963 . Review.

PMID:
18627333
18.
19.

Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.

Gray A, Wallis DE, Hursting MJ, Katz E, Lewis BE.

Clin Appl Thromb Hemost. 2007 Oct;13(4):353-61.

PMID:
17911186
20.

Overview of heparin-induced thrombocytopenia.

Spinler SA, Dager W.

Am J Health Syst Pharm. 2003 Oct 15;60 Suppl 5:S5-11. Review.

PMID:
14593977

Supplemental Content

Support Center